Human equilibrative nucleoside transporter 1 (hENT1) expression is a potential predictive tool for response to gemcitabine in patients with advanced cholangiocarcinoma

✍ Scribed by I. Borbath; L. Verbrugghe; R. Lai; J.F. Gigot; Y. Humblet; H. Piessevaux; C. Sempoux

• Book ID: 116430935
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 832 KB
• Volume: 48
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2011.11.006